Obesity trials in China

In China 249 Also abroad 1939

249 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in China
Yeast Protein Supplementation and Muscle Preservation During GLP-1RA-Induced Weight Loss
Where
Shenzhen
Age
25 years to 50 years
People
200
Run by
Huazhong University of Science and Technology
See details and how to joinNCT07817823
No phaseNot yet taking people in China
Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients
Where
Nanjing
Age
18 years to 65 years
People
80
Run by
Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT07847515
No phaseNot yet taking people in China
De Novo Gastroesophageal Reflux Disease After Sleeve Gastrectomy With and Without Omentopexy
Where
Beijing
Age
18 years to 65 years
People
140
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07854613
Phase 4Taking people
Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
Where
Beijing
Age
18 years and over
People
116
Run by
China National Center for Cardiovascular Diseases
See details and how to joinNCT07657676
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Binzhou, Chengdu, Deyang, Ganzhou, Guangzhou, Haikou, Hangzhou, Huaian, Huzhou, Jinan, Jinzhou, Kunming, Lanzhou, Linhai, Liuzhou, Luoyang, Nanchang, Nanjing, Nantong, Ningbo, Panjin, Pingxiang, Qingdao, Shanghai, Shenyang, Shenzhen, Siping, Suining, Suzhou, Ürümqi, Wanzhou, Wenzhou, Wuhan, Wuxi, Xiangyang, Xuancheng, Yibin, Yichang, Zhengzhou, Zhenjiang, Zunyi
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 3Taking people
A Study of BGM0504 in Early T2DM With Obesity
Where
Nanjing
Age
18 years to 75 years
People
372
Run by
BrightGene Bio-Medical Technology Co., Ltd.
See details and how to joinNCT07743983
Phase 3Not yet taking people in China
A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems
Where
Chengdu, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing, Shanghai
Age
18 years and over
People
192
Run by
Eli Lilly and Company
See details and how to joinNCT07790861
No phaseTaking people
Efficacy and Safety of Akkermansia Muciniphila AKM Lab-01 for Overweight and Obesity
Where
Guangzhou
Age
18 years to 60 years
People
200
Run by
Moon (Guangzhou) Biotechnology Co., Ltd.
See details and how to joinNCT07331974
Phase 3Taking people
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Where
Beijing, Guangzhou, Luoyang, Nanjing, Shenzhen, Tianjin
Age
18 years and over
People
300 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07571109 · EU 2024-520443-16-00
Phase 3Not yet taking people in China
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Where
Beijing, Changchun, Changsha, Changzhou, Chongqing, Guangzhou, Jinan, Jining, Luoyang, Nanjing, Shenyang, Shijiazhuang, Suzhou, Tianjin, Xi'an, Zhenjiang
Age
45 years to 64 years
People
8,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00
Phase 3Taking people
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Where
Beijing, Changchun, Chengdu, Jinan, Shanghai, Wuhan, Zhengzhou
Age
8 years to 18 years
People
460 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07253285 · EU 2023-509176-42-00
Phase 1Taking people
A Phase 1 Study of GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study Participants
Where
Beijing
Age
18 years to 55 years
People
126
Run by
Gan & Lee Pharmaceuticals.
See details and how to joinNCT07784699
No phaseNot yet taking people in China
Effect of Different-Flow High-Flow Nasal Cannula Versus Traditional Face Mask Oxygenation on Safe Apnea Time in Obese Patients
Where
Lianyungang
Age
18 years to 65 years
People
147
Run by
The First People's Hospital of Lianyungang
See details and how to joinNCT07843810
Phase 1Not yet taking people in China
A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple Doses
Where
Jinan
Age
18 years to 55 years
People
122
Run by
Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07841860
Phase 3Taking people
Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity
Where
Beijing, Harbin
Age
18 years to 70 years
People
648
Run by
Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07528027
Phase 4Taking people
Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)
Where
Beijing, Chengdu, Chongqing, Hefei
Age
18 years to 60 years
People
60
Run by
West China Hospital
See details and how to joinNCT07718126
No phaseTaking people
A Clinical Study on Using Multimodal Ultrasound to Assess Muscle Mass in Metabolic Diseases
Where
Zhangzhou
Age
18 years and over
People
320
Run by
Zhangzhou Municipal Hospital
See details and how to joinNCT07836088
Phase 3Not yet taking people in China
A Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents
Where
Hangzhou
Age
12 years to 17 years
People
192
Run by
Hangzhou Sciwind Biosciences Co., Ltd.
See details and how to joinNCT07836270
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Beijing, Chengdu, Guangzhou, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing, Shanghai
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
No phaseNot yet taking people in China
Efficacy of Mazdutide on Fatty Pancreas
Where
Wuhan
Age
18 years to 60 years
People
194
Run by
Tongji Hospital
See details and how to joinNCT07803705
No phaseNot yet taking people in China
Fangshan Active Nutrition Initiative
Where
Beijing
Age
8 years to 9 years
People
1,400
Run by
Peking University
See details and how to joinNCT07519122
No phaseTaking people
Nudge-Based Exercise Intervention for Adolescents With Obesity
Where
Nanjing
Age
10 years to 19 years
People
140
Run by
Nanjing Children's Hospital
See details and how to joinNCT07824453
Phase 1Not yet taking people in China
Phase 1 Clinical Study of MWN117 Injection in Healthy Participants and Participants With Obesity
Where
Kunming
Age
18 years to 55 years
People
48
Run by
Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07824804
Phase 1Not yet taking people in China
A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Study of SHR-1179 Injection in Participants With Obesity
Where
Shanghai
Age
18 years to 60 years
People
50
Run by
Guangdong Hengrui Pharmaceutical Co., Ltd
See details and how to joinNCT07826364
No phaseTaking people
Maternal Grandmothers in the Born in Guangzhou Cohort Study
Where
Guangzhou
Age
36 years to 100 years
People
5,000
Run by
Guangzhou Women and Children's Medical Center
See details and how to joinNCT03633162